Ritter Z, Oeltzschner G, Solnes LB, Liu G, Kamson DO. Diagnostic and theranostic opportunities in Neuro-oncology.
ADVANCES IN ONCOLOGY 2024;
4:111-124. [PMID:
40248613 PMCID:
PMC12001827 DOI:
10.1016/j.yao.2024.01.001]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/19/2025]
Abstract
Theranostics, the interlinking of diagnostic and therapeutic procedures, can be particularly valuable in neuro-oncology, addressing the challenges posed by the blood-brain and brain-tumor barriers. While it is traditionally associated with nuclear medicine, advances in MR imaging techniques have opened new theranostic frontiers. This review covers the present challenges in neuro-oncology and how these could be overcome utilizing radioligand-based molecular radiotherapy as well as how label-free theranostics employing methods such as chemical exchange saturation transfer (CEST) and MR spectroscopy could advance the field.
Collapse